Westaim Corporation (The) - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Westaim Corporation (The). Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Westaim Corporation (The). The Group's principal activities are to develop, manufacture and commercialize medical products that fight infection and inflammation. The Group operates through two segments: NUCRYST Pharmaceuticals and iFire Technology. NUCRYST Pharmaceuticals segment researches, develops and commercializes wound care products and pharmaceutical products based on noble metal nanocrystalline technology. iFire Technology segment develops proprietary flat-panel full color solid-state display technology. The Group operates in Canada, the United States and Europe.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report